Evidence map›Paper›PMID 34663955›Full record

ReviewNature methods2021

Time for NanoNeuro.

Aitzol Garcia-Etxarri, Rafael Yuste

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature methods, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. The New Era of Neural Modulation Led by Smart Nanomaterials.International journal of nanomedicine · 2024
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Aitzol Garcia-EtxarriDonostia International Physics Center, Donostia-San Sebastián, Spain. aitzolgarcia@dipc.org.ORCID http://orcid.org/0000-0002-5867-2390
Rafael YusteDonostia International Physics Center, Donostia-San Sebastián, Spain. rmy5@columbia.edu.ORCID http://orcid.org/0000-0003-4206-497X

Funding

IMAGING FUNCTIONAL CONNECTIVITY IN VISUAL CORTEXR01EY011787 · NEI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI YUSTE, RAFAEL · 1998 to 2021
$6.4M
Effect of GABAergic inhibition of dendritic spines on synaptic pruning in the medial prefrontal cortex during adolescenceR01MH115900 · NIMH · SUNY DOWNSTATE MEDICAL CENTER · PI SMITH, SHERYL S · 2019 to 2023
$3.2M
CRCNS: Modeling the nanophysiology of dendritic spinesR01NS110422 · NINDS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI YUSTE, RAFAEL · 2018 to 2020
$744k
Optical methods for imaging and manipulating dendritic spines in vivoR34NS116740 · NINDS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI ETCHENIQUE, ROBERTO, YUSTE, RAFAEL · 2020 to 2020
$700k
NEI NIH HHS R01 EY011787NIMH NIH HHS R01 MH115900NINDS NIH HHS R01 NS110422NINDS NIH HHS R34 NS116740
6 · The paper itself

Abstract

The study of electronic properties of materials at the nanoscale has unveiled physical laws and generated materials such as nanoparticles, quantum dots, nanodiamonds, nanoelectrodes, and nanoprobes. Independently, large-scale public and private neuroscience programs have been launched to develop methods to measure and manipulate neural circuits in living animals and humans. Here, we review an upcoming field, NanoNeuro, defined as the intersection of nanoscience and neuroscience, that aims to develop nanoscale methods to record and stimulate neuronal activity. Because of their unique physical properties, nanomaterials have intrinsic advantages as biosensors and actuators, and they may be applicable to humans without the need for genetic modifications. Thus, nanoscience could make major methodological contributions to the future of neuroscience and, more generally, to biomedical sciences.

Indexed as

NeurosciencesQuantum DotsAnimalsBiosensing TechniquesHumansNanoparticlesNanotechnology

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.